Armenian Medical NetworkHealth.am
Health centers
CancerHeart & Blood VesselsBrain & NervesMental HealthDiabetes & HormonesWeight & NutritionWomen's HealthPregnancy & FertilityChildren's HealthSexual HealthMen's HealthInfections, HIV & STIsLungs, Asthma & AllergiesDigestive HealthBones, Joints & PainSkin, Hair & BeautyEyes, Ears & TeethAddictionSleepHealthy AgingPublic HealthMedicines & Treatments

References

REFERENCES


  1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977 - 86.

  2. The United Kingdom Prospective Diabetes Study Research Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352:837 - 53.

  3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353:2643 - 53.

  4. Stratton IM, Adler AI, Neil AW, et al. on behalf of the UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321:405 - 12.

  5. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004; 350:2272 - 9.

  6. Cryer PE. Glucose homeostasis and hypoglycemia. In: Kronenberg H, Larsen PR, Melmed S, Polonsky K, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia: Elsevier, in press.

  7. The United Kingdom Prospective Diabetes Study Research Group. Overview of 6 years of therapy of type II diabetes: a progressive disease. Diabetes 1995; 44:1249 - 58.

  8. Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population based study. Diabet Med 2005; 22:749 - 55.

  9. Holstein A, Plaschke A, Egberts E-H. Clinical characteristics of severe hypoglycemia - a prospective population-based study. Exp Clin Endocrinol Diabetes 2003; 111:364 - 9.

  10. Leese GP, Wang J, Broomhall J, et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population based study of health service resource use. Diabetes Care 2003; 26:1176 - 80.

  11. American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care 2005; 28:1245 - 9.

  12. The United Kingdom Prospective Diabetes Study Research Group. A 6-year, randomized, controlled trial comparing sulfonylurea, insulin and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 1998; 128:165 - 75.

  13. Hepburn DA, MacLeod KM, Pell ACH, et al. Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 1993; 10:231 - 7.

  14. Campbell IW. Hypoglycaemia and type 2 diabetes: sulphonylureas. In: Frier BM, Fisher BM, eds. Hypoglycemia and Diabetes. Clinical and Physiological Aspects. London: Edward Arnold, 1993: 387 - 92.

  15. Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989; 321:1231 - 45.

  16. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 1993; 91:819 - 28.

  17. Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002; 51:724 - 33.

  18. Fanelli CG, Pampanelli S, Epifano L, et al. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia following institution of rational intensive therapy in IDDM. Diabetologia 1994; 37:1265 - 76.

  19. Cranston I, Lomas J, Maran A, et al. Restoration of hypoglycemia unawareness in patients with long duration insulin-dependent diabetes mellitus. Lancet 1994; 344:283 - 7.

  20. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994; 43:1426 - 34.

  21. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54:3592 - 601.

  22. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003; 26:1902 - 12.

  23. The Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90:450 - 9.

  24. Rosenstock J, Dailey G, Massi-Benedetti M, et al. Reduced hypoglycemia risk with insulin glargine. Diabetes Care 2005; 28:950 - 5.

  25. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28:1568 - 73.

  26. Wiethop BV, Cryer PE. Alanine and terbutaline in the treatment of hypoglycemia in IDDM. Diabetes Care 1993; 16:1131 - 6.